11 Feb 2021 --- UK-based life sciences company OptiBiotix is funding research into how microbiome modulation technologies could affect sleep, stress and anxiety. Also funded by Italian research institute Fondazione Edmund Mach Centro Ricerca e Innovazione (FEM) and the University of Southampton, UK, the study will examine in depth how prebiotics and probiotics could impact and aid periods of stress-induced insomnia.
